Efrain Reisin
Nephrology · New Orleans, LANPI 1750302774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 25.5% of the total.
Across 34 payments — averaging $69.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$605
- Amgen$483
- Vifor Pharma, Inc.$247
- Sanofi$149
- AstraZeneca$145
- GSK$122
- plus $620 from 10 others
Across 54 payments — averaging $3938.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$125K
- GSK$39K
- Vertex$25K
- Gilead$23K
What the payments were for
- Food & beverage$2,372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 7 | $605 |
| Amgen(2 entities) | 5 | $483 |
| Vifor Pharma, Inc. | 3 | $247 |
| Sanofi | 2 | $149 |
| AstraZeneca(2 entities) | 2 | $145 |
| GSK | 2 | $122 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Bayer | 1 | $100 |
| Aurinia Pharma U.S., Inc. | 1 | $98 |
| Nxstage Medical, Inc. | 1 | $73 |
| Calliditas Therapeutics US Inc. | 1 | $72 |
| Fresenius USA Marketing, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Travere Therapeutics, Inc. | 1 | $31 |
| Akebia Therapeutics Inc | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,372 in reported general payments places this provider in the 55th percentile of 206 nephrology providers in Louisiana.
Other nephrology in New Orleans
- Juan Carlos VelezNew Orleans$282K
- Michael TouchyNew Orleans$56K
- Juan MedauraNew Orleans$14K
- Farshid YazdiNew Orleans$14K
- Mihran NaljayanNew Orleans$10K
- Rhea BhargavaNew Orleans$9K
- April FoxNew Orleans$8K
- Myra KleinpeterNew Orleans$7K
- Joshua LowentrittNew Orleans$7K
- Angela ReginelliNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.